Light microscopy remained central, but twentieth-century medicine added
new ways to visualize small structures. In 1930 the Dutch physicist
Frits Zernike discovered the phase-contrast principle, which let
observers study living transparent cells without killing and staining
them; the first phase-contrast microscopes were manufactured in 1941,
and he received the 1953 Nobel Prize in Physics for the method. In 1941,
Albert Coons and colleagues at Harvard Medical School labeled
antibodies with a fluorescent dye and used them to locate antigens in
tissue, founding immunofluorescence.
Electron microscopy pushed medical vision below the limits of visible
light. In 1931, Max Knoll and Ernst Ruska built an early transmission
electron microscope in Berlin; improved instruments soon produced images
of bacteria and virus particles, and Siemens produced a commercial
electron microscope in 1939. Applied widely after the Second World
War, the electron microscope made viruses, organelles, membranes, and
ultrastructure visible in new detail. This did not replace ordinary
histology, but it changed virology, cell biology, renal pathology,
neuromuscular diagnosis, and research on cell structure. Ruska received
the 1986 Nobel Prize in Physics for the instrument.
Later immunohistochemistry, molecular probes, automated scanners, and
digital pathology further changed microscopy's place in medicine. The
slide became part of a wider technical system that could include
antibodies, computers, image archives, remote consultation, and
standardized reporting.